Rose Marino

Rose Marino is an accomplished medical professional with extensive experience in clinical development and medical leadership within the pharmaceutical industry. Currently serving as Chief Medical Officer at Glycomine Inc., Rose has held pivotal roles at Ipsen as Vice President of Clinical Development for Rare Diseases and at Clementia Pharmaceuticals Inc., progressing from Medical Director to Senior Medical Director as the company became part of Ipsen. Previous experience also includes the position of Associate Medical Director at Alkermes. Rose holds a Bachelor of Science in Chemical Engineering from the Massachusetts Institute of Technology and a Medical Doctor degree from Stony Brook University Health Sciences Center School of Medicine.